ML20126D080: Difference between revisions

From kanterella
Jump to navigation Jump to search
StriderTol Bot insert
 
StriderTol Bot change
 
Line 18: Line 18:


=Text=
=Text=
{{#Wiki_filter:_    _
{{#Wiki_filter:f D15 ; toIV50 C.
f -                                                                                                                    D15 ; toIV50 C.
~D T
  '    ~D T
y
              ,. ur                                                                                                         "            y ag jo,,
,. ur ag n 6'70 - I jo,,
n 6'70 - I 8              o UNITED STATES NUCLEAR REGULATORY COMMISSION g
UNITED STATES 8
g             ;E                                                     WASHINGTON, D. C. 20555                       "
NUCLEAR REGULATORY COMMISSION g
re et  % figg Q#ch *
o g
              * * * *
;E WASHINGTON, D. C. 20555
* p$                                                                                                       ,
% figg Q#ch
V W 2 5 1994 $#%             [s m c. k on,a d' i;>nss/pQirMB MEMORANDUM FOR:                                       Vandy L. Miller, Chief Material Licensing Branch Division of Fuel Cycle and Material Safety FROM:                                                 Thomas F. Dorian                                                           i Attorney, Regulations Division Office of the Executive Legal Director
* r et e
* * * *
* p$
V W 2 5 1994 $#%
[s m c. k on,a d' i;>nss/pQirMB MEMORANDUM FOR:
Vandy L. Miller, Chief Material Licensing Branch Division of Fuel Cycle and Material Safety FROM:
Thomas F. Dorian i
Attorney, Regulations Division Office of the Executive Legal Director


==SUBJECT:==
==SUBJECT:==
 
REQUEST FOR COMMENTS ON PROPOSED RULEMAKING TO AUTHORIZE j
REQUEST FOR COMMENTS ON PROPOSED RULEMAKING TO AUTHORIZE                   j APPROVED RADI0 PHARMACEUTICALS FOR UNAPPROVED USES                         (
APPROVED RADI0 PHARMACEUTICALS FOR UNAPPROVED USES
l We have reviewed the proposed rule. In general it appears fine. Our few comments are noted on the enclosure.
(
                                                                                                  +4 f homas F. Dorian n'n        -
l We have reviewed the proposed rule.
I l
In general it appears fine. Our few comments are noted on the enclosure.
+4 f n'n I
homas F. Dorian l
Attorney, Regulations Division l
Attorney, Regulations Division l
Office of the Executive Legal Director
Office of the Executive Legal Director
Line 40: Line 49:
==Enclosures:==
==Enclosures:==
As stated i
As stated i
i 0506140630 850611 PDR     PR
i 0506140630 850611 PDR PR 35 PDR
    ,    35                                                   PDR
____ _. _ _ _ _ _. _ _ _ _ _ _. _}}
____ _ . _ _ _ _ _ . _ _ _ _ _ _ . _}}

Latest revision as of 19:53, 12 December 2024

Forwards Comments on Proposed Rulemaking to Authorize Approved Radiopharms for Unapproved Uses
ML20126D080
Person / Time
Issue date: 10/25/1984
From: Dorian T
NRC OFFICE OF THE EXECUTIVE LEGAL DIRECTOR (OELD)
To: Miller V
NRC OFFICE OF NUCLEAR MATERIAL SAFETY & SAFEGUARDS (NMSS)
Shared Package
ML20126D070 List:
References
FRN-50FR15752, RULE-PR-35 AB72-1, NUDOCS 8506140630
Download: ML20126D080 (1)


Text

f D15 ; toIV50 C.

~D T

y

,. ur ag n 6'70 - I jo,,

UNITED STATES 8

NUCLEAR REGULATORY COMMISSION g

o g

E WASHINGTON, D. C. 20555

% figg Q#ch

  • r et e
  • * * *
  • p$

V W 2 5 1994 $#%

[s m c. k on,a d' i;>nss/pQirMB MEMORANDUM FOR:

Vandy L. Miller, Chief Material Licensing Branch Division of Fuel Cycle and Material Safety FROM:

Thomas F. Dorian i

Attorney, Regulations Division Office of the Executive Legal Director

SUBJECT:

REQUEST FOR COMMENTS ON PROPOSED RULEMAKING TO AUTHORIZE j

APPROVED RADI0 PHARMACEUTICALS FOR UNAPPROVED USES

(

l We have reviewed the proposed rule.

In general it appears fine. Our few comments are noted on the enclosure.

+4 f n'n I

homas F. Dorian l

Attorney, Regulations Division l

Office of the Executive Legal Director

Enclosures:

As stated i

i 0506140630 850611 PDR PR 35 PDR

____ _. _ _ _ _ _. _ _ _ _ _ _. _